SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

Novo Nordisk Wins FDA Approval for Weekly Growth Hormone in Children With Turner Syndrome

The FDA approved Novo Nordisk's Sogro for weekly growth hormone treatment in children with Turner syndrome.

NVO

Related stories